Menu
GWAS Study

Diverse ancestry whole-genome sequencing association study identifies <i>TBX5</i> and <i>PTK7</i> as susceptibility genes for posterior urethral valves.

Chan MMY, Sadeghi-Alavijeh O, Lopes FM et al.

36124557 PubMed ID
GWAS Study Type
23859 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CM
Chan MMY
SO
Sadeghi-Alavijeh O
LF
Lopes FM
HA
Hilger AC
SH
Stanescu HC
VC
Voinescu CD
BG
Beaman GM
NW
Newman WG
ZM
Zaniew M
WS
Weber S
HY
Ho YM
CJ
Connolly JO
WD
Wood D
MC
Maj C
SA
Stuckey A
KA
Kousathanas A
KR
Kleta R
WA
Woolf AS
BD
Bockenhauer D
LA
Levine AP
GD
Gale DP
Chapter II

Abstract

Summary of the research findings

Posterior urethral valves (PUV) are the commonest cause of end-stage renal disease in children, but the genetic architecture of this rare disorder remains unknown. We performed a sequencing-based genome-wide association study (seqGWAS) in 132 unrelated male PUV cases and 23,727 controls of diverse ancestry, identifying statistically significant associations with common variants at 12q24.21 (p=7.8 × 10-12; OR 0.4) and rare variants at 6p21.1 (p=2.0 × 10-8; OR 7.2), that were replicated in an independent European cohort of 395 cases and 4151 controls. Fine mapping and functional genomic data mapped these loci to the transcription factor TBX5 and planar cell polarity gene PTK7, respectively, the encoded proteins of which were detected in the developing urinary tract of human embryos. We also observed enrichment of rare structural variation intersecting with candidate cis-regulatory elements, particularly inversions predicted to affect chromatin looping (p=3.1 × 10-5). These findings represent the first robust genetic associations of PUV, providing novel insights into the underlying biology of this poorly understood disorder and demonstrate how a diverse ancestry seqGWAS can be used for disease locus discovery in a rare disease.

89 European ancestry cases, 19,418 European ancestry controls, 18 South Asian ancestry cases, 2,847 South Asian ancestry controls, 11 African ancestry cases, 449 African ancestry controls, 7 Hispanic or Latin American controls, 14 Other admixed ancestry cases, 1,006 Other admixed ancestry controls

Chapter III

Study Statistics

Key metrics and study information

23859
Total Participants
GWAS
Study Type
Yes
Replicated
395 European ancestry cases, 4,151 European ancestry controls
Replication Participants
European, South Asian, African unspecified, Other admixed ancestry, Hispanic or Latin American
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.